Neuromuscular Disorders
Volume 16, Issue 8 , Pages 530-538 , August 2006

135th ENMC International Workshop: Nutrition in Amyotrophic Lateral Sclerosis 18–20 of March 2005, Naarden, The Netherlands

  • A.C. Ludolph

      Affiliations

    • On behalf of the Nutrition in ALS Group.
    • Corresponding Author InformationTel.: +49 731 0177 1200.

Received 29 March 2006

References 

  1. Desport JC, Preux PM, Truong TC, et al. Nutritional Status is a Prognostic Factor for Survival in ALS Patients. Neurology. 1999;3:1059–1063
  2. Kasarskis EJ, Scarlata D, Hill R, et al. A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci. 1999;169(1–2):118–125
  3. Desport JC, Preux PM, Magy L, et al. Factors correlated with hypermetabolism in amyotrophic lateral sclerosis patients. Am J Clin Nutr. 2001;74:328–334
  4. Heffernan C, Jenkinson C, Holmes T, et al. Nutritional management in MND/ALS patients: an evidence based review. ALS and other motor neuron disorders, vol. 5; 2004. p. 72–83.
  5. Dupuis L, Oudart H, Rene F, Gonzalez der Aguilar Jl, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc natl Acad Sci USA. 2004;101:11159–11164
  6. Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence based review). Neurology. 1999;52:1311–1323
  7. Ludolph AC. Amyotrophe Lateralsklerose (Motoneuronerkrankungen). In: Leitlinien der Deutschen Gesellschaft für Neurologie. Hrsg. Georg Thieme Verlag, Stuttgart, New York. p. 153–7.
  8. Rothstein JD. Of mice and men: reconciling preclinical ALS mouse studies and human clinical trials. Ann Neurol. 2003;53(4):423–426
  9. Watts J. Controversy in China. Lancet. 2005;365:109–110
  10. Desport JC, Preux PM, Bouteloup-Demange C, et al. Validation of bioelectrical impedance analysis in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2003;77:1179–1185
  11. Chiò A, Galletti R, Finocchiaro C, et al. Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS. J Neurol Neurosurg Psychiatry. 2004;75:645–647
  12. Forbes RB, Colville S, Swingler RJ, et al. Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis: motor neurone disease. J Neurol. 2004;251:813–817
  13. Chiò A, Finocchiaro E, Meineri P, Bottacchi E, Schiffer D. Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. Neurol. 1999;53:1123–1125
  14. Wollman B, D'Agostino HB, Walus-Wigle JR, et al. Radiologic, endoscopic and surgical gastrostomy: an institutional evaluation and meta analysis of the literature. Radiology. 1995;195:699–704
  15. Thornton FJ, Fotheringham T, Alexander M. Amyotrophic lateral sclerosis: enteral nutrition provision—endoscopic or radiologic gastrostomy?. Radiology. 2002;224(3):713–717
  16. Smith RA, Melmed S, Sherman B, et al. Recombinant growth hormone treatment of amyotrophic lateral sclerosis. Muscle Nerve. 1993;16:624–633
  17. Silani V, Kasarskis EJ, Yanagisawa N. Nutritional management in amyotrophic lateral sclerosis: a worldwide perspective. J Neurol. 1998;245:13–19
  18. Desport JC, Preux PM, Truong CT, et al. Nutritional assessment and survival in ALS patients. ALS and other motor neuron disorders, vol. 1; 2000. p. 91–6.
  19. Nau KL, Bromberg MB, Forshew DA, Katch VL. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci. 1995;129:47–49
  20. Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, Clain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr. 1996;63:130–137
  21. Mazzini L, Corra T, Zaccal M, et al. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol. 1995;242:695–698
  22. Selberg O, Selberg D. Norms and vorrelates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol. 2002;86:509–516
  23. Sano M, Ernesto C, Thomasm R, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimerapos;s disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 1997;336:1216–1222
  24. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol. 1996;39:147–157
  25. Ascherio A, Weisskopf MG, O'Reilly EJ, et al. Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann Neurol. 2005;57:104–110
  26. Desnuelle C, Dib M, Garrel C, et al. A double blind, placebo-controlled randomised clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group. ALS and other motor neuron disorders, vol. 2; 2000. p. 9–18.
  27. Graf M, Ecker D, Horowski R, et al. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm. 2005;112:649–660
  28. Simpson EP, Yen AA, Appel SH. Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis. Curr Opin Rheumatol. 2003;15:730–736
  29. Traynor BJ, Codd MB, Corr B, et al. Incidence and prevalence of ALS in Ireland, 1995–1997, A population based study. Neurol. 1999;52:504–509
  30. Kidney D, Alexander M, Corr B, O'Toole O, Hardiman O. Oropharyngeal dysphagia in amyotrophic lateral sclerosis: neurological and dysphagia specific rating scales. ALS and other motor neuron disorders, vol. 5; 2004. p. 150–3.
  31. Thornton FJ, Fotheringham T, Alexander M, et al. Amyotrophic lateral sclerosis: enteral nutrition provision—endoscopic or radiologic gastrostomy?. Radiology. 2002;224:713–717
  32. Morgan RK, McNally S, Alexander M, et al. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171:269–274
  33. Long J. Nutritional Management of ALS. Oral presentation ALS Alliance Symposium 2005, Philadelphia, PA, USA.
  34. Mathus-Vliegen LM, Louwerse LS, Merkus MP, Tytgat GN, Vianney-de-Jong JM. Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function. Gastrointest Endosc. 1994;40:463–469
  35. Light VL, Slezak FA, Porter JA, Gerson LW, McCord G. Predictive factors for early mortality after percutaneuous endoscopic gastrostomy. Gastrointest Endosc. 1995;43:330–335
  36. Boitano LJ, Jordan T, Benditt JO. Non-invasive ventilation allows gastrostomy tube placement in patients with advanced ALS. Neurology. 2001;56(3):413–414
  37. Gregory S, Siderowff A, Golaszewski A, McCluskey L. Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival. Neurology. 2002;58:485–487
  38. Ersek M. Artificial Nutrition and Hadration: clinical issues. J Hospice Palliat Nurs. 2003;5:221–230
  39. Mitsumoto H, Davidson M, Moore D, et al., Anderson FA and the ALS CARE Study Group. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. ALS and other motor neuron disorders, vol. 4; 2003. p. 177–85.
  40. Cullinane M, Gray AJG, Hargraves CMK, et al. Scoping ur practice. The national confidential enquiry into patient outcome and death survey; 2004.
  41. Weekes CE, Elia M, Emery PW. The development, validation and reliability of a nutrition screening tool based on the recommendations of the British Association for Parenteral and Enteral Nutrition (Bapen). Clin Nutr. 2004;23:1104–1112

PII: S0960-8966(06)00119-2

doi: 10.1016/j.nmd.2006.04.005

Neuromuscular Disorders
Volume 16, Issue 8 , Pages 530-538 , August 2006

Article Tools

* Image Usage & Resolution